Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luning Wang

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
Aging|September 18, 2018
The etiological effect of a new low-frequency Xiaoling Li, Xiaoquan Zhu, Wandong Zhang, et al.
Cell Death and Differentiation|May 10, 2022
Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancerJinrui Zhang, Ge Zhang, Wenjing Zhang, et al.
Nature|August 21, 2023
Quinone-mediated hydrogen anode for non-aqueous reductive electrosynthesisJack Twilton, Mathew R Johnson, Vinayak Sidana, et al.
The Journal of Clinical Investigation|October 5, 2021
RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11Wenjing Zhang, Yu Sun, Lu Bai, et al.
Chinese Medical Journal|January 24, 2014
Construction of the Chinese Veteran Clinical Research (CVCR) platform for the assessment of non-communicable diseasesJiping Tan, Nan Li, Jing Gao, et al.
Alzheimer'S Research & Therapy|March 18, 2021
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementiaShifu Xiao, Piu Chan, Tao Wang, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Aging|September 18, 2018
The etiological effect of a new low-frequency Xiaoling Li, Xiaoquan Zhu, Wandong Zhang, et al.
Cell Death and Differentiation|May 10, 2022
Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancerJinrui Zhang, Ge Zhang, Wenjing Zhang, et al.
Nature|August 21, 2023
Quinone-mediated hydrogen anode for non-aqueous reductive electrosynthesisJack Twilton, Mathew R Johnson, Vinayak Sidana, et al.
The Journal of Clinical Investigation|October 5, 2021
RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11Wenjing Zhang, Yu Sun, Lu Bai, et al.
Chinese Medical Journal|January 24, 2014
Construction of the Chinese Veteran Clinical Research (CVCR) platform for the assessment of non-communicable diseasesJiping Tan, Nan Li, Jing Gao, et al.
Alzheimer'S Research & Therapy|March 18, 2021
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementiaShifu Xiao, Piu Chan, Tao Wang, et al.
Pageof 13